Company ProfilePremium

Nutritional Holdings Limited

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Nutritional Holdings Limited - Company showcase

Year Founded & Workforce

2004

102 Employees

Nutritional Holdings Limited logo

Nutritional Holdings Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Nutritional Holdings Limited Overview

Nutritional Holdings Limited is a small South African investment holding company. It was built around Nutritional Foods (Pty) Ltd, a fortified staple dry-food maker in Klerksdorp whose business traces back to 1947. The group sold maize-based porridges, soya mince, beverages and instant meals to institutional and mass-market customers. From 2016 it tried several diversifications: Kairos Nutrition (infant feeding), Venlai Strategic Solutions (renewable energy and security distribution), and from late 2019 cannabis through Ukusekela Holdings. Ukusekela's cannabis-extract "Ultimate Immune Booster" drove the group's first reported profit in seven years (FY2020), alongside very large announced export supply contracts. That pivot then ran into a series of governance failures:

  • a qualified audit opinion;

  • loss of control over the food subsidiary;

  • results that were restated;

  • frequent changes of finance directors;

  • liquidation proceedings brought by a former director.

These events led to JSE suspension in May 2021 and termination of the listing in December 2022. Today the company is an unlisted entity whose operating status has not been disclosed.


Company's own description. Before it was suspended, the company described itself in its listing particulars as an investment holding company. Its interests covered the manufacture, marketing and distribution of staple dry foods, cannabis infusions, oils, extracts and related edibles [S5]. Earlier handbook entries described a mass-market food business with recognised brands in the LSM 3–6 consumer segment, diversified by product, geography and urban/rural spread. The company argued that the capital cost of replicating its factory was a barrier to entry [S1]. The last reviewed interim report (H1 FY2021) organised the group into two operating activities: Foods and Cannabis [S6].

Independent characterisation. In practice the group was a single-factory food processor whose revenue never exceeded about R43 million a year in the five audited years from FY2016 to FY2020 [S1]. Losses before FY2020 were funded mainly by shareholder loans [S6]. The cannabis business started as a management agreement under which Nutritional Holdings managed Ukusekela Holdings for its own profit and loss while the acquisition was pending [S7]. The acquisition took effect on 1 October 2020 [S6]. Revenue from this business was reported as "Services" in the segment note [S6].

Business and revenue model.

Strategy

Stated strategy (paraphrased from company disclosures).

  1. 2016 diversification: The board concluded that a small AltX food company could not raise the capital needed to compete with established food manufacturers. It chose to diversify into the industrial and manufacturing sectors through reverse listings of assets held by Ontario Private Equity, starting with VSS [S11].

  2. 2019–2020 cannabis pivot and five-year plan: Manage and then acquire Ukusekela; distribute CBD products through European and African pharmaceutical partners; position the group as a leader in South Africa's regulated cannabis industry [S6, S7]. Media coverage reported a target mix of about 70% food and 30% cannabis [S18].

  3. FY2020 "Action Plan":

    • kiosks across African regional markets, backed by e-commerce;

    • instant-meal supply to the Gulf region (above R250 million a year);

    • forecast Ultimate Immune Booster sales of R83 million over six months;

    • cannabis-infused instant meals for oncology patients [S7].

  4. 2021 portfolio reset: Dispose of Nutritional Foods as non-core and use the proceeds to fund Ukusekela's growth [S30, S33].

  5. 2022 rebuild: Under a written commitment from a group of new investors, keep both Nutritional Foods and Ukusekela, recommission the Klerksdorp plant, reconstitute the board with experienced South African independent directors, and complete the overdue audits on a roadmap agreed with the JSE [S38, S40].

  6. Post-delisting intention: Bring the financial statements up to date, reverse the liquidation, protect the underlying assets, and consider a new listing on the JSE or another South African exchange [S46, S47].

Initiatives in the last 24 months (October 2024 – October 2026): None publicly disclosed.

Medium-term targets and guidance: No quantified financial targets beyond the FY2020 Action Plan forecasts. None of those forecasts appears in any audited results.

ESG and cost programmes: In FY2020 the company said it had cut administrative costs and cash burn and redirected marketing and R&D spending to higher-return programmes [S7]. No quantified targets were given.

Products & Services

Foods (Nutritional Foods (Pty) Ltd, Klerksdorp).

Packaging ranges from 50 kg bulk bags to 30 g single-serve sachets. The plant holds ISO 22000 accreditation and complies with HACCP and GMP standards [S15]. Product rows are drawn from [S15] (FY2015 profile) and [S6, S7] (2020–2021).

Nutrition and diversified acquisitions.

Cannabis (Ukusekela Holdings).

None of the cannabis products above has disclosed specifications, registration status with the South African Health Products Regulatory Authority (SAHPRA), or audited revenue beyond the FY2020 and H1 FY2021 segment figures.

Product Portfolio

Product lineDescription / capabilityTarget customerLaunch / versionPricing disclosed

Fortified maize-based porridges

Extruded fortified staple, produced on twin-screw extrusion lines

Industrial catering; mass market LSM 3–6

—

No

Soya mince (textured vegetable protein)

Extruded TVP

Industrial catering; retail

—

No

Powdered soft drinks

Dry-blended beverages

Industrial catering; retail

—

No

Isotonic drinks

Dry-blend sports and rehydration drinks

Industrial; sport

—

No

Gravies, spices and coatings

Savoury blends

Catering ingredients

—

No

Milk powder blends and creamers

Dairy blends

Catering; retail

—

No

"Twin pouch" meal replacement

Meal-replacement format for heavy industry and mining

Mining and heavy industry

Described as new in 2015

No

Instant High Energy Meal

Instant meal; planned to be made at the Durban head office under the Nutritional Holdings brand

Schools, correctional facilities, army bases, sports facilities, NGOs/NPOs

Highlighted 2020–2021

No

Instant Rehydrate

Rehydration product

Camping and outdoor, sport, remote medical kits, army, NGOs

Highlighted 2020–2021

No

Instant meals for the Gulf region

Proposed supply contract above R250 million a year, through existing relationships of the then CEO

Gulf-region buyers

Announced Sept 2020; never evidenced in published results

No

“—” = not publicly disclosed.

OfferingDescriptionSource

Kairos Nutrition infant feeds

Infant feed supplied under contracts to fight malnutrition; run by registered dietician Michelle Bristow

[S10]

VSS energy and security solutions

Accredited distributor of Bosch renewable energy and security solutions to commercial and industrial clients

[S11]

ProductDescriptionTarget / channelPricing / volume disclosedSource

The Ultimate Immune Booster with Cannabis Extract

Flagship product; produced with a proprietary infusion process attributed to founder N. Dasarath

South African retail; Germany via GIH Distributors

First delivery of 72,000 units worth about R32 million, implying roughly R444 per unit (derived). Contract volumes of 50,000 units a month in year 1, rising to 200,000 a month by year 3.

[S6, S21, S22]

CBD Body Balm

CBD topical

Japan and Asia via Grovenor Supplements FZCO, Ajman (UAE)

Part of a R776.1 million, 24-month off-take

[S6]

CBD oils and infused products

Supplied under an off-take with Europharm Medical Corporation

European distribution in more than 15 countries (claimed)

—

[S6]

Medical cannabis edibles (oncology)

Cannabis-infused instant meals for cancer and terminally ill patients; samples planned for September 2020

Oncology practitioners

Company-estimated market of R500 million a year in Africa and R2.5 billion globally

[S7]

CBD pet care

Reported as a development area

Pet owners

—

[S18]

CO2 extraction (Indiva Pharma)

Supercritical CO2 cannabinoid extraction facility

Internal and B2B extraction

Acquisition unwound in 2022

[S6, S38]

Retail kiosks and e-commerce

Planned kiosks in regional markets across Africa, with online back-end and nationwide delivery

Consumers

Not implemented, as far as published reporting shows

[S7]

“—” = not publicly disclosed.

Financial Narrative

Scope. The five most recent audited years are FY2016 to FY2020. FY2021 and FY2022 were never published [S46], and FY2023 to FY2026 are not publicly disclosed. FY2016–FY2020 data come from Profile's Stock Exchange Handbook [S1], cross-checked against SENS results [S6, S8]. Derived figures are labelled. Blank cells are not publicly disclosed.

Income statement

Notes on the income statement:

Not publicly disclosed: gross profit, EBITDA (depreciation and amortisation not available), and diluted EPS beyond basic (reported as identical where shown).

FY2019 operating loss: ZAR -3,617k per the SENS interim comparative [S8]. Profile records ZAR -3,776k [S1]. The SENS figure reconciles exactly to the reported pre-tax loss of ZAR -5,402k.

FY2020 headline figures: the short-form FY2020 announcement gave turnover of ZAR 41,729k, profit of ZAR 7,473k and EPS of 0.05c [S7]. The audited comparatives later printed in the reviewed restated interims show turnover of ZAR 40,829k, profit of ZAR 5,941k and EPS of 0.04c [S6].

FY2017 loss per share: the trading statement guided basic loss per share of 0.471–0.503c and headline loss per share of 0.227–0.259c [S13]. Profile's HEPS of -0.24c falls within that range.

Dividends: no distributions are recorded in any reviewed source. The board said in 2021 that it was "reviewing" its dividend policy [S6].

Revenue CAGR FY2016–FY2020: 1.6% a year (derived).

Cumulative net loss FY2016–FY2019: ZAR -41,629k (derived).

Commentary. Revenue stayed between R38 million and R43 million throughout, so the business never broke out of micro-cap scale. The trough came in FY2017 (operating margin -34.4%), when management cited extremely difficult trading conditions in staple dry foods [S12].

The FY2020 "turnaround" needs careful reading:

  • Group operating profit was only ZAR 1,285k.

  • After finance costs of ZAR 1,842k, the group made a pre-tax loss of ZAR 557k.

  • The reported net profit of ZAR 5,941k came entirely from a deferred-tax credit of ZAR 6,498k [S6].

  • On a pre-tax basis, FY2020 was the fifth consecutive loss-making year.

  • The improvement in segment terms came from Services (management-agreement income of ZAR 5,552k pre-tax), which offset a Foods pre-tax loss of ZAR 6,109k [S6].

Interim periods (latest available)

Source: [S6]. The columns are three views of two periods: H1 FY2020 (six months to 31 August 2019) and H1 FY2021 (six months to 31 August 2020), first as published on 14 December 2020 and then as restated on 9 June 2021.

ShareData Online records the restated interim with attributable income of ZAR -1.1 million and consolidation-adjusted EPS of 1.00c [S4]. That conflicts with the +ZAR 5,967k profit in the SENS document [S6]. The difference is not explained in the reviewed sources.

Balance sheet

FY2020 detail (audited, ZAR 000) [S6]:

Notes on the balance sheet:

  • The FY2020 total of ZAR 48,021k matches the audited balance sheet exactly [S6].

  • Net debt for FY2016–FY2019 is approximate because Profile rounds the debt-to-equity ratio to two decimals. The FY2020 figure is computed directly from the balance sheet.

  • The FY2020 short-form announcement gave FY2019 NAV per share as 1.31c [S7], against Profile's 1.73c [S1].

  • The statement of changes in equity shows an accumulated loss of ZAR -146,427k [S6], against ZAR -147,426k in the balance sheet. The ZAR 999k inconsistency appears in the source itself.

  • Treasury shares carried at ZAR 6,741k correspond to 90 million shares, the gap between 13,743,368k issued and 13,653,368k net of treasury (derived).

Commentary.

  • Equity fell from ZAR 40.2 million (FY2016) to ZAR 13.9 million (FY2018) as losses accumulated.

  • The accumulated deficit of about R147 million at FY2020, against R159.6 million of contributed capital, shows that most capital raised since listing had been lost.

  • Equity rose from ZAR 13,854k to ZAR 17,946k in FY2019 despite a ZAR 5,402k loss. That implies about ZAR 9.5 million of equity movements other than earnings, such as share issues or revaluations (derived). Their composition is not disclosed in the reviewed sources.

  • Funding came almost entirely from shareholder loans, which grew to ZAR 17.8 million at FY2020 and ZAR 20.1 million at August 2020 [S6]. A former director later went to court over one such loan of R9,449,137 [S40].

  • The FY2020 balance sheet relied on a ZAR 6.5 million deferred tax asset. For a company with five straight pre-tax losses, recognising that asset is open to question.

Cash flow

Source: [S6]. Cash flow data before FY2020 are not publicly disclosed in the reviewed sources. The restated H1 FY2021 statement repeats ZAR -602k as net investing cash flow, which looks like a presentation error in the source.

Commentary. Operating cash flow was negative in every disclosed period, including the period of the reported cannabis "profits". Profit was not turning into cash. Group cash at August 2020 was ZAR 165k (restated) [S6], and the business depended on new shareholder loans to keep going.

Ratios

Sources: ROE, current ratio and D:E from Profile [S1]; the rest derived.

Ratios not available:

ROIC and net debt to EBITDA: EBITDA is not disclosed.

Cash conversion cycle: cost of sales is not disclosed.

Receivable days: derived only for FY2020, at about 124 days (ZAR 13,923k ÷ ZAR 40,829k × 365). That is a long collection period for a food processor.

Commentary.

  • Interest cover was below 1.0x in every year.

  • FY2020's 25.5% ROE comes from the tax credit. On a pre-tax basis ROE was negative.

  • FY2018's current ratio of 0.76x marked a liquidity low point. It recovered in FY2019, consistent with the unexplained equity increase and higher shareholder loans.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRelationshipActivityStatus (latest disclosed)

Nutritional Holdings Limited

Parent

Investment holding

Unlisted since 19 Dec 2022; liquidation proceedings, outcome not disclosed [S46]

Nutritional Foods (Pty) Ltd

Wholly owned subsidiary [S41]

Dry-food manufacturing, Klerksdorp [S8, S15]

Deconsolidated for loss of control (June 2021) [S6]; reconsolidation decided March 2022 [S38]; liquidation application set for February 2023 in Mahikeng [S44]; outcome not disclosed

Ukusekela Holdings (Pty) Ltd

Wholly owned subsidiary from 1 Oct 2020 [S6, S22]

Cannabis research, infusion and products

Production on hold in April 2022 pending renewal of lapsed licences [S40]

Kairos Nutrition (Pty) Ltd

Acquired effective 1 May 2016 [S10]

Infant feeds

Later status not publicly disclosed

Venlai Strategic Solutions (Pty) Ltd

Acquisition effective 1 Nov 2016, subject to a profit warranty [S11]

Distribution of Bosch renewable energy and security products

Whether the deal closed or the profit warranty was met is not publicly disclosed

Indiva Pharma LLC (business and assets)

Acquired November 2020 [S6]

CO2 cannabis extraction

Acquisition unwound (March 2022); shares to be cancelled [S38]

Revenue by Segment and Revenue by Segment (%)

MetricH1 FY2020FY2020H1 FY2021

Foods external revenue (ZAR K)

16,70332,53513,412

Services/Cannabis external revenue (ZAR K)

08,29420,312

Services internal revenue (ZAR K)

300300—

Group revenue (ZAR K)

16,70640,82933,724

Foods profit before tax (ZAR K)

-3,078-6,109-2,381

Services profit before tax (ZAR K)

-1,6525,55218,155

Foods share of group revenue (%)

100.079.739.8

Services share of group revenue (%)

0.020.360.2

Foods pre-tax margin (%)

-18.4-18.8-17.8

Services pre-tax margin (%)

—66.989.4

Income Statement and Margin Analysis (%)

MetricFY2016FY2017FY2018FY2019FY2020

Revenue (ZAR K)

38,26943,21542,49637,87640,829

Revenue growth YoY (%)

—12.9-1.7-10.97.8

Operating profit/(loss) (ZAR K)

-4,692-14,870-7,263-3,6171,285

Net finance costs (ZAR K)

7101,3361,5351,7851,842

Profit/(loss) before tax (ZAR K)

———-5,402-557

Income tax credit/(charge) (ZAR K)

———06,498

Net profit/(loss) attributable (ZAR K)

-5,414-17,031-13,782-5,4025,941

Headline EPS (ZAR cents, pre-consolidation)

-0.16-0.24-0.31-0.060.04

Dividends per share (ZAR cents)

00000

Operating margin (%)

-12.26-34.41-17.09-9.553.15

Net margin (%)

-14.15-39.41-32.43-14.2614.55

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Balance Sheet and Per-Share Data

MetricH1 FY2020H1 FY2021 as first publishedH1 FY2021 reviewed restated

Revenue (ZAR K)

16,70633,72420,312

Operating profit/(loss) (ZAR K)

-3,77316,47618,761

Net finance costs (ZAR K)

-957-701-566

Profit/(loss) before tax (ZAR K)

-4,73015,77418,195

Taxation (ZAR K)

0-5,142-5,142

Loss on asset held for disposal (ZAR K)

00-7,086

Net profit/(loss) (ZAR K)

-4,73010,6325,967

HEPS (ZAR cents, pre-consolidation)

-0.030.080.04

Total assets (ZAR K)

39,24960,71747,475

Total equity (ZAR K)

13,21633,70619,333

Balance Sheet and Per-Share Data (Annual)

MetricFY2016FY2017FY2018FY2019FY2020

Property, plant & equipment (ZAR K)

24,76424,73023,73023,21422,752

Total current assets (ZAR K)

9,66414,0358,2399,64317,543

Total equity (ZAR K)

40,21027,61513,85417,94623,294

Non-current liabilities (ZAR K)

12,61615,37114,33417,96718,194

Current liabilities (ZAR K)

5,7467,17010,7863,9816,533

Total assets, derived as equity + liabilities (ZAR K)

58,57250,15638,97439,89448,021

Working capital, derived (ZAR K)

3,9186,865-2,5475,66211,010

Approximate net debt, derived from Profile's D:E × equity (ZAR K)

13,67116,84518,56418,84319,314

NAV per share (ZAR cents, pre-consolidation)

1.200.800.401.732.19

Financial Analysis

Line itemZAR K

Intangible assets (goodwill and intangibles)

1,228

Deferred tax asset

6,498

Inventories

3,251

Trade and other receivables

13,923

Cash and cash equivalents

369

Bank overdraft

1,199

Loans from shareholders (non-current)

17,821

Lease liabilities (non-current)

373

Lease liabilities (current)

290

Trade and other payables

5,044

Total debt (shareholder loans + leases + overdraft), derived

19,683

Net debt, derived

19,314

Share capital net of treasury shares

159,580

Accumulated loss

-147,426

Cash Flow

MetricH1 FY2020FY2020H1 FY2021 restated

Net cash from operating activities (ZAR K)

-1,079-2,197-602

Capital expenditure (ZAR K)

-1,406-1,5640

Free cash flow, derived (ZAR K)

-2,485-3,761-602

Shareholder loans received (ZAR K)

3,0004,0201,597

Dividends paid (ZAR K)

000

Share buybacks (ZAR K)

000

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2016FY2017FY2018FY2019FY2020

Return on equity (%)

-13.46-61.67-99.48-30.1025.50

Return on assets, derived (%)

-9.24-33.96-35.36-13.5412.37

Current ratio (x)

1.681.960.762.402.69

Debt to equity, Profile net basis (x)

0.340.611.341.050.83

Asset turnover, derived (x)

0.650.861.090.950.85

Interest cover, operating profit ÷ net finance costs, derived (x)

-6.61-11.13-4.73-2.030.70

Disclosed or Claimed Geography Details

Disclosed or claimed geographySegmentNatureEvidence status

South Africa

Foods; Cannabis

Domestic manufacturing and sales; national sales channels for the Ultimate Immune Booster (claimed)

Revenue by country not disclosed [S7]

Southern Africa

Foods

Distribution network

Qualitative only [S1]

Germany

Cannabis

Ultimate Immune Booster via GIH Distributors (contract stated above R1 billion over 3 years)

One delivery of about R32 million announced March 2021 [S21]; not evidenced in any audited accounts

UAE (Ajman) for Japan and Asia

Cannabis

CBD products via Grovenor Supplements FZCO (R776.1 million, 24 months)

Supply said to have started (May 2021) [S27]; not evidenced in audited accounts

Europe (15+ countries)

Cannabis

Off-take via Europharm Medical Corporation

Qualitative only [S6]

Gulf region

Foods

Proposed instant-meal contract above R250 million a year

Not evidenced [S7]

Lesotho, Zimbabwe, Eswatini

Cannabis

Cultivation, manufacture and trade licences held by Ukusekela

Licences reported lapsed by April 2022 [S6, S40]

Per-Share Data

MetricFY2016FY2017FY2018FY2019FY2020

Share price high (ZAR cents)

52212

Share price low (ZAR cents)

11111

Share price period end (ZAR cents)

21111

3-year beta

1.732.403.711.571.06

Observation by Date

DateObservation

Oct 2020

Average 11 million shares a week, R115,246 a week (4.2% annualised turnover)

Jan 2021

Average 51 million shares a week, R527,490 a week (19.3% annualised turnover)

26 May 2021

Last possible trading day before suspension

16 Dec 2022

Last recorded close 25c (post-consolidation, equal to 1c before consolidation), no volume; market capitalisation R167.4 million

Valuation Snapshot

MultipleValueBasis

P/E

23.1x

Uses tax-driven net profit of ZAR 5.94 million. On a pre-tax basis the company made a loss, so P/E is not meaningful.

P/B

5.9x

Equity of ZAR 23.3 million

EV/Sales

3.8x

EV = R137.4 million + net debt of R19.3 million

Analyst Conclusions

Management guidance. No current guidance exists. The last forward-looking statements, from December 2022, committed to:

  • bringing the financial statements up to date;

  • reversing the liquidation;

  • protecting the underlying assets, including Nutritional Foods;

  • considering a relisting once the company was regularised [S46, S47].

Consensus growth expectations. None (no analyst coverage).

Bull case.

  1. Tangible asset base. The Klerksdorp extrusion plant had a carrying value of about ZAR 22.8 million at FY2020 (property, plant and equipment) [S1] and food-safety accreditation [S15]. A recapitalised owner could restart production for institutional feeding without greenfield capex.

  2. Investor sponsorship. An investor group committed in writing in April 2022 to support regularisation [S40]. If the liquidation was set aside, a cleaned-up shell with two operating subsidiaries could be relisted, as the board indicated [S46].

  3. Cannabis optionality. Ukusekela's licences in three Southern African jurisdictions and its branded product could regain value if renewed [S6, S40], especially as South African cannabis policy liberalises [S7].

Bear case.

  1. Solvency. A final liquidation order was granted on 2 August 2022 [S43]. With no public evidence of rescission, shareholders' equity may already have been lost.

  2. Earnings never independently confirmed. FY2020 profit depended on tax, the interims were restated, the audit was qualified [S6], and the large contracts never showed up in published audited revenue [S27].

  3. Governance record. Repeated management turnover, related-party disposal attempts, lost subsidiary control and allegations about directors' loan security [S6, S33, S41] would make any relisting difficult.

Catalysts and monitorables (next 12 months).

Analyst verdict. Nutritional Holdings Limited is best understood as a failed micro-cap turnaround, not an investable operating company. Over the five audited years to FY2020, revenue never exceeded R43.2 million. Operating losses peaked at 34% of revenue in FY2017, and about R41.6 million of losses between FY2016 and FY2019 were funded through dilutive share issues and shareholder loans. The company's own board admitted in 2016 that it lacked the resources to compete in branded staple foods.

The 2019–2020 cannabis pivot gave the appearance of a recovery. Looked at closely, however, the FY2020 "first profit in seven years" was a pre-tax loss turned positive by a R6.5 million deferred-tax credit. The H1 FY2021 profit came from a management agreement whose 89% margin preceded actual ownership of Ukusekela. The contracts announced in 2020, worth more than R1.7 billion combined, were at least twelve times the company's market value and were concentrated in one Dubai-linked group. Audited revenue to support them was never published.

Governance then broke down step by step:

  1. a qualified audit;

  2. restated interims;

  3. loss of control of the food subsidiary;

  4. a related-party sale that collapsed;

  5. four finance chiefs in about 20 months;

  6. suspension, liquidation proceedings and finally delisting.

For research purposes, the entity now has the characteristics of a dormant or distressed shell. Its residual value depends on court outcomes and on the condition of the Klerksdorp plant and the cannabis licences, none of which has been reported publicly since December 2022. Any counterparty, investor or acquirer should verify CIPC status and court records first, and should treat all pre-2022 forward-looking claims, especially contract values, as unsubstantiated until audited accounts appear. Absent such evidence, the base case assumes that ordinary shareholders have little or no recoverable value.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleTenure (as disclosed)Background (as disclosed)

G.R. Wambach

Chairman

Recorded by ShareData; appointment date not disclosed

—

Helena Dorothea ("Althea") Grewar

Executive Director and Chair

From 1 Sep 2021; end not disclosed

CGMSA; 17 years in pharmaceuticals; more than 7 years at Certified Master Auditors (South Africa) Inc.

Sheikh Khalfan Humaid Nasser (AKHA Belhoul / "K Nassar")

Independent non-executive Chairman, then INED from 1 Sep 2021

Chair by 2020 to Sep 2021

BCom and MBA (Zayed University, UAE); former UAE Ministry of Interior and police; real estate developer

Mohammad Tariq Azum

CEO and Executive Director

In office by FY2020 (start not disclosed) to 8 Jun 2021

Led the cannabis pivot; stepped down citing COVID-related ill health

Nikhyle Dasarath

Executive Director, then CEO

ED from 16 Mar 2021; CEO from 7–8 Jun 2021; Nutritional Foods board from 27 Mar 2022

Founder and CEO of Ukusekela; honours diploma in software engineering; master-grower training

Neville Moodley

Executive Director / COO, then Financial Director

Appointed 1 Sep 2020; FD from 28 Mar 2022

Described as both non-executive and executive in different SENS announcements

Pieter Watson CA(SA)

Financial Director / CFO

From 22 Apr 2021; succeeded as FD by 28 Mar 2022

Chartered accountant

Suzanne Meyer

CFO

29 Oct 2020 – 28 Feb 2021

Oversaw the December 2020 interims that were later restated

Rammalane Monye

Financial Director

Resigned July 2020

—

Sashen Nessa Reddy

Executive Director (Financial Manager)

22 Apr 2021 – 6 Sep 2021

—

M.M. Suping

Executive Director; CEO of Nutritional Foods

Through at least 2021

Bid for Nutritional Foods through Mmabakgosi Properties

S. (M.S.) Tinawi

Independent NED; chair of Audit & Risk Committee

2020–2021

—

Dr Adel Al Tinawi

NED (Pharmaceutical Development)

1 Sep 2020 – 10 May 2021

Pharmacist based in Lyon; master's in clinical evaluation (University of Lyon)

Tony Kahano Kyubwa

Independent NED

1 Sep 2020 – 6 Sep 2021

—

Boy Manqoba Ngubo

Independent NED; Audit Committee

From 10 May 2021

Trained at BDO; interim CFO at Joburg Market SOC; NED of PSV Holdings

Basil Mashabane

Independent NED

From 6 Sep 2021

Attorney; former Deputy Executive Director, Takeover Regulation Panel; LLB, LLM, MSc

Igmar Rautenbach CA(SA)

Independent NED

From 28 Mar 2022

Trained at Ernst & Young; qualified CA in 2001; master's in SA tax; CIMA

Cobus Kotze

Independent NED

From 28 Mar 2022

BA LLB (Stellenbosch)

Thabo Mokgatlha

Non-executive Director

Resigned 1 Sep 2020

—

P.M. Chabeli; T. Mashaba; Dr P. Mokgothu

Independent NED; NED; independent NED

Listed in 2020 handbooks

—

Ian Murgatroyd

Commercial Director

From 25 Apr 2016

Former Kairos director; 12+ years in pharmaceuticals and FMCG

John Ellis; Jan Louw

Non-executive Directors

From 12 Jul 2012

Founding members of E2E and Nutritional Holdings; involved in the listing

“—” = not publicly disclosed.

Major Shareholders

HolderStake (%)Date

Baphalane Ba Mantserre (printed as "Baphalane Ba Mantserred")

68.39

28 Feb 2019

Philisani

7.28

28 Feb 2019

Empire Cannabis & Noms

65.11

29 Feb 2020

Competitive Landscape

Key Competitors

CompetitorSegment overlapPositioning relative to Nutritional HoldingsLatest disclosed revenue

Tiger Brands

Staple foods (grains, maize, porridge)

Largest South African food producer; grains division alone had R7.1 billion revenue in FY2025 [S50]

R34.4 billion (FY Sep 2025) [S50]

RCL Foods

Groceries, baking, sugar, pet food

Broad-line JSE food manufacturer, about 10,500 employees [S51]

R26.5 billion (FY Jun 2025) [S51]

Libstar Holdings

Ambient and perishable packaged foods, including dry condiments and spices

Mid-cap multi-category FMCG producer

R12.3 billion (FY Dec 2025) [S52]

PepsiCo South Africa (Pioneer Foods)

Breakfast cereals and porridges

Multinational-owned staple brands

—

Premier Group

Maize milling, baking

Integrated miller and baker

—

Nestlé South Africa

Fortified cereals and dairy blends

Multinational with fortified product lines

—

Labat Africa

Cannabis (Lesotho licences via Zarenka)

Fellow JSE small cap that entered cannabis in 2019 [S16]

—

Lesotho-licensed medical cannabis producers (several)

Cannabis cultivation and extraction

Competing licence-based export models

—

South African CBD retail and supplement brands (many)

CBD consumer products

Fragmented retail market

—

Institutional and school-feeding suppliers

Fortified instant meals

Tender-based competition

—

Peer Comparison FY2025

MetricNutritional Holdings (FY2020)Tiger Brands (FY2025)RCL Foods (FY2025)Libstar (FY2025)

Revenue (ZAR Mn)

40.834,40026,50012,329

Revenue growth (%)

7.82.71.88.2

Profitability margin (%)

3.1 (operating)

11.0 (operating, derived)

9.7 (EBITDA, derived)

8.7 (normalised EBITDA, derived)

Recent Developments

Final disclosed newsflow (May 2021 – February 2023): * These are the last 18-plus months of public disclosure.

Company Snapshot

$2.5M

Revenue

102

Employees

2004

Founded

SWOT Analysis

Strengths

  • Installed processing capacity: 8,000 m² Klerksdorp plant with two twin-screw extrusion lines and multiple blending and packaging lines [S15]
  • Food-safety credentials: ISO 22000 accreditation; HACCP and GMP compliance (FY2015) [S15]
  • Heritage asset: Food business dating to 1947, formerly owned by Tongaat Milling [S15]
  • Institutional channel access: Instant meals for schools, correctional facilities, army bases and NGOs [S6]
  • Shareholder funding support: Shareholder loans of ZAR 17.8 million at FY2020; majority shareholder guarantee for cash shortfalls (H1 FY2021) [S6]
  • Regional cannabis licences (historic): Ukusekela licences in Lesotho, Zimbabwe and Eswatini plus a South African laboratory [S6]

Weaknesses

  • Chronic losses: Cumulative net loss of ZAR 41.6 million over FY2016–FY2019; accumulated loss of ZAR 147.4 million at FY2020 [S1, S6]
  • Quality of earnings: FY2020 profit came entirely from a ZAR 6.5 million deferred tax credit; pre-tax loss of ZAR 0.56 million [S6]
  • Cash burn: Negative operating cash flow in every disclosed period (FY2020: ZAR -2.2 million) [S6]
  • Reporting reliability: Qualified FY2020 audit opinion; interims restated; conflicting FY2020 figures across announcements [S6, S7]
  • Governance instability: Four finance heads between July 2020 and March 2022; three or more Designated Advisers; executive chair from September 2021 [S6, S32, S35, S39]
  • Loss of subsidiary control: Holding board could not direct Nutritional Foods; deconsolidated in June 2021 [S6]

Opportunities

  • Cannabis liberalisation in South Africa: 2020 State of the Nation commitment on hemp and medicinal cannabis [S7]
  • Plant recommissioning: March 2022 plan to rebuild Nutritional Foods and recommission plant [S38]
  • Investor-led recapitalisation: Written commitment from an investor group in April 2022 [S40]
  • Relisting: Board said it would consider a new listing once the company was regularised [S46]
  • Product extensions: CBD pet care and oncology edibles under development [S7, S18]
  • Institutional feeding demand: Instant High Energy Meal channels (schools, army, NGOs) [S6]

Threats

  • Liquidation: Final liquidation order of 2 August 2022; outcome of the January 2023 hearing undisclosed [S43, S46]
  • Creditor litigation: Former director's claim of R9,449,137 [S40]
  • Regulatory and licensing: Ukusekela production halted pending renewal of lapsed licences [S40]
  • Loss of capital-markets access: JSE listing terminated 19 December 2022 [S46]
  • Incumbent competition: Tiger Brands at R34.4 billion and RCL at R26.5 billion revenue [S50, S51]
  • Counterparty concentration: Both large export contracts with one Dubai group (Ashmore) [S27]

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
–*April 2025 – October 2026** No material development by or about Nutritional Holdings Limited was found in the sources reviewed. The company has published no SENS announcements since delisting in December 2022. It has not published audited results for FY2021 to FY2026, and has not disclosed the outcome of the January 2023 liquidation hearing.

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

2 charts
Revenue by Segment: Foods external revenue fell from ZAR 16.7 Mn in H1 FY2020 to ZAR 13.4 Mn in H1 FY2021.
Nutritional Holdings Limited — Revenue by Segment
Series (ZAR Mn)H1 FY2020FY2020H1 FY2021
Foods external revenue16.732.513.4
Services/Cannabis external revenue08.320.3
Services internal revenue0.30.3—
Group revenue16.740.833.7
Foods profit before tax-3.1-6.1-2.4
Services profit before tax-1.75.618.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. S1Profile's Stock Exchange Handbook 2020, Issue 4, p.182: NUT financial statistics FY2016–FY2020, directors, shareholders (profile.co.za)
  2. S2Profile's Stock Exchange Handbook 2021, Issue 1, p.185: H1 FY2021 statistics, shareholder 65.11% (profile.co.za)
  3. S3Profile's Stock Exchange Handbook 2020, Issue 3, p.184 (profile.co.za)
  4. S4ShareData Online: NUT main page (suspended, market capitalisation, latest results) (sharedata.co.za)
  5. S5ShareData Online: NUT summary fact sheet (sharedata.co.za)
  6. S6SENS, 9 Jun 2021: reviewed restated interim results, six months to 31 Aug 2020 (senspdf.jse.co.za)
  7. S7SENS, 1 Sep 2020: FY2020 short-form results (senspdf.jse.co.za)
  8. S8SENS: interim results, six months to 31 Aug 2019 (senspdf.jse.co.za)
  9. S9SENS, 14 Dec 2020: unaudited interim results (senspdf.jse.co.za)
  10. S10SENS, 25 Apr 2016: Kairos Nutrition acquisition (sharedata.co.za)
  11. S11SENS, 7 Nov 2016: change in strategy, VSS acquisition (sharedata.co.za)
  12. S12SENS, 24 Apr 2017: trading statement (sharedata.co.za)
  13. S13SENS, 11 May 2017: further trading statement (sharedata.co.za)
  14. S14SENS, 13 Jul 2012: board changes (sharedata.co.za)
  15. S15Engineering News, 21 Aug 2015: Nutritional Foods profile (engineeringnews.co.za)
  16. S16Business Day, 17 Dec 2019: Nutritional bids for cannabis grower Ukusekela (businesslive.co.za)
  17. S17BizNews / CNBC Africa (2020): Nutritional Holdings benefits from cannabis deal (biznews.com)
  18. S18CNBC Africa, 15 Sep 2020: results interview summary (cnbc.africa)
  19. S19SENS, 3 Sep 2020: changes to the board (senspdf.jse.co.za)
  20. S20SENS, 24 Feb 2021: proposed disposal and correction (senspdf.jse.co.za)
  21. S21SENS, 8 Mar 2021: German consortium deliveries (senspdf.jse.co.za)
  22. S22SENS, 17 Mar 2021: Dasarath appointment (senspdf.jse.co.za)
  23. S23SENS, 26 Mar 2021: Designated Adviser resignation (senspdf.jse.co.za)
  24. S24SENS, 30 Mar 2021: AcaciaCap appointment (senspdf.jse.co.za)
  25. S25SENS, 22 Apr 2021: FD appointment and board composition (senspdf.jse.co.za)
  26. S26SENS, 10 May 2021: changes to the board (senspdf.jse.co.za)
  27. S27SENS, 11 May 2021: supply contracts update (senspdf.jse.co.za)
  28. S28SENS, 13 and 18 May 2021: share consolidation (senspdf.jse.co.za)
  29. S29SENS, 3 Jun 2021: consolidation clarification (senspdf.jse.co.za)
  30. S30SENS, 19 May 2021: Nutritional Foods disposal and business rescue withdrawal (senspdf.jse.co.za)
  31. S31SENS, 8 Jun 2021: CEO change (senspdf.jse.co.za)
  32. S32CFO South Africa: Dasarath appointed CEO (cfo.co.za)
  33. S33SENS, 18 Jun 2021: Nutritional Foods disposal agreement (senspdf.jse.co.za)
  34. S34SENS, 30 Jun 2021: suspension update and delayed results (senspdf.jse.co.za)
  35. S35SENS, 1 Sep 2021: new chairperson (senspdf.jse.co.za)
  36. S36SENS, 7 Sep 2021: board resignations and appointment (senspdf.jse.co.za)
  37. S37SENS, 16 Sep and 15 Oct 2021: cautionary renewals (senspdf.jse.co.za)
  38. S38SENS, 22 Mar 2022: Nutritional Foods and Indiva update (senspdf.jse.co.za)
  39. S39SENS, 28 Mar 2022: INED appointments (senspdf.jse.co.za)
  40. S40SENS, 29 Apr 2022: quarterly suspension update (senspdf.jse.co.za)
  41. S41SENS, 7 Jun 2022: provisional judgement update (senspdf.jse.co.za)
  42. S42SENS, 20 Jul 2022: provisional liquidation update (senspdf.jse.co.za)
  43. S43SENS, 10 Aug 2022: opposition to final liquidation (senspdf.jse.co.za)
  44. S44SENS, 21 Sep 2022: cautionary renewal (senspdf.jse.co.za)
  45. S45SENS, 4 Oct 2022: liquidation update (senspdf.jse.co.za)
  46. S46SENS, 13 Dec 2022: quarterly update and termination of listing (senspdf.jse.co.za)
  47. S47IOL Business Report, 14 Dec 2022: Nutritional Holdings to delist (iol.co.za)
  48. S48MarketScreener: Nikhyle Dasarath profile (ca.marketscreener.com)
  49. S49African Markets: NUT company page (african-markets.com)
  50. S50Tiger Brands: FY2025 results release (tigerbrands.com)
  51. S51RCL Foods: FY2025 results press release (rclfoods.com)
  52. S52Libstar: FY2025 results (SENS) and revenue data (sharedata.co.za)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.